Benzinga | Nov 19, 2021 07:02AM EST

Microbot Medical Reports Secured Added Patent For LIBERTY Robotic System In US

Microbot Medical Inc. (NASDAQ:MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance for a second patent application covering the Company's LIBERTY(r) Robotic System. Globally, the Company now has 46 patents issued/allowed and 24 pending patent applications and is continuously submitting applications to protect its Intellectual Property.

"We believe that the U.S. is the largest and most significant market opportunity for the LIBERTY(r) Robotic System, and with two allowances in a few short months, it clearly demonstrates the innovative nature of our technology," commented Harel Gadot, CEO, President and Chairman. "2022 is poised to be an important year for the LIBERTY(r) Robotic System. It's critical that we approach this period knowing we have protections in place, so we can ultimately monetize our Intellectual Property, reap potential commercial opportunities and maximize shareholder value."

The allowed claims cover a modular robotic system for manipulation of at least two elongated, flexible surgical tools, the system including at least one unit operable to move a first tool and a base operable to move a second tool, wherein the base serves as a mounting for the units, and each unit communicates with the base in one of a mechanical coupling, electrical power supply and data communication.